🔥 Monday 20 April 2026 Mon, 20 Apr 2026

Nuix has completed its acquisition of Paris-based Linkurious, integrating advanced graph data visualisation technology and boosting its full year Annualised Contract Value guidance to $252 million–$272 million.

Yancoal’s March quarter report reveals stable coal output amid rising diesel prices pushing operating costs higher, alongside progress on its $2.6 billion Kestrel Coal Mine acquisition. The company’s safety performance improved and market coal prices gained momentum, with realized price benefits expected from Q2.

Nutritional Growth Solutions (ASX: NGS) has completed a major operational reset, achieving normalised profitability, eliminating all debt, and replenishing inventory to support renewed growth.

The Federal Court of Australia has approved the merger of Diversified United Investment Limited (DUI) with Australian United Investment Company Limited (AUI), paving the way for the scheme to become effective by the end of April. Eligible DUI shareholders will receive approximately 0.47241 AUI shares for each DUI share held.

African Gold Ltd’s takeover by Montage Gold Corp moves a step closer as the Supreme Court of Western Australia approves its Share and Option Schemes, triggering suspension of trading and setting key dates for implementation.

Stanmore Resources defied a four-year low in metallurgical coal prices to deliver record saleable production and robust cash flow in 2025, while maintaining a strong safety record and advancing key development projects.

VHM Limited has ditched its Shenghe Resources offtake agreement to broaden market options and approved a direct jump to full-scale 5Mtpa development at its Goschen Rare Earths and Mineral Sands Project. Key regulatory approvals and a major drilling campaign underpin progress towards a mid-2026 Final Investment Decision and production slated for late 2027.

BPM Minerals has reported compelling high-grade gold assay results from maiden drilling at its Beachcomber Prospect and secured A$3.5 million in a strategic placement to fund an expanded 2026 exploration campaign across its Forelands Gold Project.

Terrain Minerals has completed a critical four-hole diamond drilling program at its Lightning Gold Project, securing key structural and density data that de-risks the upcoming maiden Mineral Resource Estimate scheduled for July 2026. The results confirm continuity of high-grade gold mineralisation, underpinning the project's transition from exploration to resource definition.

AnteoTech (ASX: ADO) pushed forward its advanced battery and life sciences technologies in the March 2026 quarter, achieving key product validations and expanding its sales pipeline to record levels. The company ended the period with A$3.3 million cash and no debt following a recent A$3.5 million capital raise.

Sunshine Metals (ASX:SHN) has delivered strong final assay results from its extensive grade control drilling at Liontown, revealing multiple high-grade gold and silver intercepts that bolster the case for a resource upgrade and a revised mining study scheduled for mid-2026.

Nexalis Therapeutics has advanced its IRX-211 program by screening the first patient in a pivotal Phase 2 trial for Breakthrough Cancer Pain, aiming to address a significant unmet need in oncology supportive care.

Peel Mining has agreed to sell its South Cobar Copper Project to Aeris Resources, while spinning off its remaining Cobar Basin assets into a new ASX-listed company, Spectre Metals. Exploration highlights from the Southern Nights Complex and Nombinnie Prospect underpin the growth potential of the new entity.

Lumos Diagnostics has secured a key FDA 510(k) clearance with CLIA waiver for its FebriDx rapid test, unlocking a US$1 billion-plus market opportunity and triggering milestone payments exceeding US$6 million. The company reported a 37% revenue jump in Q3 FY26, supported by a A$20 million placement and ongoing clinical and development projects.

Diablo Resources has extended high-grade silver, antimony, and copper mineralisation at its Star Range Project in Utah, with assays hitting 534 g/t silver and 0.19% antimony. The company is advancing toward a maiden drilling program scheduled for Q2 2026.

4DMedical lands a contract with pharma giant GSK, gains UKCA certification for its CT:VQ™ lung imaging technology, and joins the S&P/ASX 200, marking a significant step in its global expansion.

High-Tech Metals has kicked off a 5,000-metre drilling campaign at its Mt Fisher gold project to unlock significant resource expansion potential. An independent review revealed that less than 60% of known mineralised intercepts are included in the current resource, highlighting substantial upside.

ASX has successfully deployed Release 1 of its CHESS system, introducing a modern clearing platform designed to handle increased trading volumes and improve resilience. The rollout marks a key step in ASX's technology modernisation strategy, with Release 2 on track for 2029.

Carnavale Resources has reinforced the high-grade nature of its Kookynie Gold Project with new drilling results, keeping its Bankable Feasibility Study on track for early Q3 2026 completion. The project’s robust economics and resource upgrades underpin growing investor interest.

Botala Energy has secured a significant A$1.45 million investment from a new African cornerstone shareholder, lifting regional ownership to around 12% and supporting ongoing drilling and feasibility work at its Serowe Coal Bed Methane project.

Axel REE Limited has achieved a key operational milestone in its in situ recovery (ISR) development at the Woolrich deposit within the Caladão Project, confirming strong rare earth element leach performance under low-impact magnesium sulphate conditions.

Kinetiko Energy is advancing a staged development strategy to unlock its 6 trillion cubic feet gas resource in South Africa, targeting first revenues within 18 months through a capital-efficient, risk-managed approach.

Critical Metals Corp has consolidated its stake in the Tanbreez Rare Earths Project, gaining government approval to increase ownership to 92.5%, while European Lithium retains a 7.5% interest. This clearance removes a key hurdle, enabling the project’s development to accelerate.

Emyria has unveiled the Empax Global Partnership Program, a high-margin clinical delivery platform targeting international drug sponsors amid growing demand for psychedelic-assisted mental health treatments.